By Puyaan Singh Jan 12 (Reuters) - Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry ...
At a J.P. Morgan media event Tuesday, the Gilead C-suite seemed to be walking on air as they highlighted Yeztugo’s capture of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results